Access brought to you by: LOCKSS
Login
Primary Efficacy End Point at Week 12
AK, actinic keratosis; c-PDT, conventional photodynamic therapy; DL-PDT, daylight photodynamic therapy.
Reproduced with permission from RM Szeimies, MD, PhD.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.